Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

A7L387 (A7L387_9PSED) Pseudomonas sp ID Ps23/309

Metallo-beta lactamase protein UniProtKBAFDB90v4InterProInteractive Modelling

266 aa; Sequence (Fasta) ; 35 identical sequences

Available Structures

86 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
VIM-2-2, Discovery of novel inhibitor scaffolds against the metallo- beta-lactamase VIM-2 by SPR ba…homo-2-mer31-263
ZN;WL3;OH;CL;
Assess
VIM-2-OX, Discovery of novel inhibitor scaffolds against the metallo- beta-lactamase VIM-2 by SPR b…homo-2-mer31-263
OH;ZN;CL;
Assess
Directed evolutionary changes in MBL super family - VIM-2 Round 10homo-2-mer30-261
ZN;GOL;
Assess
The structure of the metallo-beta-lactamase VIM-2 in complex with a triazolylthioacetamide 1bhomo-2-mer32-262
ZN;CL;MG;NA;9RX;ACT;FMT;
Assess
VIM-2 metallo-beta-lactamase in complex with ((S)-3-mercapto-2-methylpropanoyl)-L-tryptophan (Compo…monomer30-263
ZN;R59;FMT;BEZ;
Assess
Structure of metallo beta lactamase VIM-2 with cyclic boronate APC308.monomer31-263
KDZ;KL8;ZN;CL;
Assess
Crystal Structure of the VIM-2 Acquired Metallo-beta-Lactamase in Complex with the thiazolecarboxyl…monomer31-263
ZN;ACT;QKK;
Assess
Crystal structure of the VIM-2 acquired metallo-beta-Lactamase in complex with compound 28 (JMV-703…monomer30-262
ZN;ACT;7ZN;
Assess
VIM-2-1, Discovery of novel inhibitor scaffolds against the metallo- beta-lactamase VIM-2 by SPR ba…monomer31-263
ZN;RHU;CL;OH;
Assess
Crystal Structure of VIM-2 with Compound 16monomer31-263
ZN;L8J;ACT;
Assess
Crystal structure of the metallo-beta-lactamase VIM-2 with L-captoprilmonomer32-263
NA;X8Z;FMT;ZN;
Assess
Structure of VIM-2 metallo-beta-lactamase with hydrolysed Faropenem imine productmonomer32-263
QZH;ZN;CL;MG;NA;
Assess
Crystal structure of the metallo-beta-lactamase VIM-2monomer32-263
NA;FMT;ZN;
Assess
Crystal structure of the metallo-beta-lactamase VIM-2 with D-captoprilmonomer32-263
NA;MCO;FMT;ZN;
Assess
Metallo beta-lactamase VIM2 with compound AK4monomer32-263
ZJ5;ZN;CL;NA;
Assess
Crystal structure of the metallo-beta-lactamase VIM-2 with 2Cmonomer32-263
FMT;ZN;OK3;DMS;
Assess
Structure of VIM-2 with 2-Mercaptomethyl-thiazolidine D-syn-1bmonomer32-263
ZN;FMT;QST;
Assess
Crystal Structure Of VIM-2 Metallo-beta-lactamase In Complex With Inhibitor X2monomer31-262
ZN;FMT;E1C;
Assess
Crystal structure of VIM-2 in complex with triazole-based inhibitor OP24monomer32-263
ZN;FMT;N8Z;
Assess
Crystal structure of the metallo-beta-lactamase VIM2 with 139monomer32-263
ZN;R9K;FMT;
Assess
Crystal Structure of the Acquired VIM-2 Metallo-beta-Lactamase in Complex with ANT-330 Inhibitormonomer32-263
ZN;ACT;JTY;
Assess
Crystal structure of the VIM-2 acquired metallo-beta-Lactamase in Complex with compound 14 (JMV-693…monomer32-263
ZN;ACT;UNL;
Assess
Crystal structure of the VIM-2 acquired metallo-beta-Lactamase in Complex with compound 8 (JMV-7207)monomer32-263
ZN;ACT;1TH;
Assess
Crystal structure of the VIM-2 acquired metallo-beta-Lactamase in Complex with compound 10 (JMV-721…monomer32-263
ZN;ACT;UNL;
Assess
VIM-2 metallo-beta-lactamase in complex with 2-(3-fluoro-4-hydroxyphenyl)-3-oxoisoindoline-4-carbox…monomer32-262
ZN;FMT;
Assess
VIM-2 metallo-beta-lactamase in complex with 2-(2-chloro-6-fluorobenzyl)-3-oxoisoindoline-4-carboxy…monomer31-261
ZN;6UW;FMT;GOL;
Assess
Structure of VIM-2 with 2-Mercaptomethyl-thiazolidine L-anti-1bmonomer32-262
ZN;QT2;FMT;
Assess
Crystal structure of VIM-2 MBL in complex with (2-(4-phenyl-1H-1,2,3-triazol-1-yl)benzyl)phosphonic…monomer32-262
ZN;ITV;
Assess
Crystal structure of VIM-2 with hydrolyzed faropenem (ring-open form)monomer32-262
FMT;ZN;QZH;
Assess
Crystal Structure of VIM-2 metallo-beta-lactamase in complex with ML302 and ML302Fmonomer32-262
ZN;S3C;SVB;FMT;DMS;
Assess
Crystal Structure Of VIM-2 Metallo-beta-lactamase In Complex With Inhibitor NO9monomer32-262
ZN;MG;NO9;FMT;
Assess
VIM-2_1dj- Triazole inhibitors with promising inhibitor effects against antibiotic resistance metal…monomer32-262
ZN;OH;CL;9O8;IOD;
Assess
Metallo-Beta-Lactamase VIM-2 in complex with Dual MBL/SBL Inhibitor MS01monomer32-262
ZN;BHU;FMT;GOL;
Assess
Crystal structure of VIM-2 metallo-beta-lactamase in complex with 10-HHIAmonomer32-262
ZN;FMT;
Assess
Crystal structure of VIM-2 MBL in complex with 1-isopropyl-1H-imidazole-2-carboxylic acidmonomer32-262
ZN;HKU;FMT;
Assess
Crystal structure of VIM-2 MBL in complex with 1-cyclobutyl-1H-imidazole-2-carboxylic acidmonomer32-262
ZN;HM0;FMT;
Assess
Crystal structure of VIM-2 MBL in complex with 1-(4-(trifluoromethyl)benzyl)-1H-imidazole-2-carboxy…monomer32-262
ZN;HML;GOL;
Assess
Metallo-Beta-Lactamase VIM-2 in complex with Dual MBL/SBL Inhibitor MS19monomer32-262
ZN;BY0;FMT;
Assess
Crystal structure of VIM-2 MBL in complex with 3-(4-(4-(2-aminoethoxy)phenyl)-1H-1,2,3-triazol-1-yl…monomer32-262
ZN;IU7;
Assess
Crystal structure of VIM-2 complexed with compound 14monomer32-262
ZN;M3Q;ACT;
Assess
Crystal Structure OF VIM-2 Metallo-beta-lactamasemonomer32-262
ZN;FMT;
Assess
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-(2-(thiophen-2-yl)ethyl)thiazole-4-carb…monomer32-262
ZN;60J;
Assess
VIM-2 Metallo Beta Lactamase in complex with 3-(mercaptomethyl)-[1,1'-biphenyl]-4-carboxylic acidmonomer32-262
S5Z;FMT;ZN;
Assess
Metallo-Beta-Lactamase VIM-2 in complex with (S)-N-(3-(2H-tetrazol-5-yl)phenyl)-3-mercapto-2-methyl…monomer32-262
ZN;FMT;G0O;
Assess
Crystal structure of VIM-2 MBL in complex with 1-propyl-1H-imidazole-2-carboxylic acidmonomer32-262
ZN;HKR;FMT;
Assess
Crystal structure of VIM-2 MBL in complex with 1-((2-aminobenzo[d]thiazol-6-yl)methyl)-1H-imidazole…monomer32-262
ZN;HQF;PEG;
Assess
Crystal structure of VIM-2 MBL in complex with (R)-1-(sec-butyl)-1H-imidazole-2-carboxylic acidmonomer32-262
ZN;HL3;FMT;
Assess
Crystal Structure of the Acquired VIM-2 Metallo-beta-Lactamase in Complex with ANT-431 Inhibitormonomer32-262
ZN;ACT;G1N;
Assess
VIM-2 metallo-beta-lactamase in complex with (R)-2-(4-hydroxyphenyl)-2-((S)-3-mercapto-2-methylprop…monomer32-262
ZN;8PO;FMT;
Assess
Crystal structure of VIM-2 MBL in complex with 1-(but-3-en-1-yl)-4-methyl-1H-imidazole-2-carboxylic…monomer32-262
ZN;HQR;GOL;
Assess
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-isobutylthiazole-4-carboxylic acidmonomer32-262
ZN;5IY;
Assess
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-(thiophen-2-ylmethyl)thiazole-4-carboxy…monomer32-262
ZN;5ZU;
Assess
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-(but-3-en-1-yl)thiazole-4-carboxylic ac…monomer32-262
ZN;5YT;
Assess
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-pentylthiazole-4-carboxylic acidmonomer32-262
ZN;5Z2;FMT;
Assess
Crystal structure of VIM-2 MBL in complex with 1-(4-hydroxybenzyl)-1H-imidazole-2-carboxylic acidmonomer32-262
ZN;HN9;FMT;
Assess
Crystal structure of VIM-2 MBL in complex with 1-(but-3-en-1-yl)-1H-imidazole-2-carboxylic acidmonomer32-262
ZN;HLF;GOL;
Assess
Crystal structure of VIM-2 MBL in complex with 1-(2-(1H-1,2,3-triazol-1-yl)ethyl)-1H-imidazole-2-ca…monomer32-262
ZN;HLL;
Assess
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-phenethylthiazole-4-carboxylic acidmonomer32-262
ZN;5ZX;FMT;
Assess
Crystal Structure of VIM-2 metallo-beta-lactamase in complex with ML302Fmonomer32-262
ZN;S3C;FMT;
Assess
Crystal Structure of the Acquired VIM-2 Metallo-beta-Lactamase in Complex with ANT-90 Inhibitormonomer32-262
ZN;U8K;CL;ACT;
Assess
VIM-2-NAT, Discovery of novel inhibitor scaffolds against the metallo- beta-lactamase VIM-2 by SPR …monomer31-261
OH;ZN;CL;
Assess
Crystal structure of VIM-2 MBL in complex with 3-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)phthalic …monomer32-262
ZN;IU3;
Assess
Metallo-Beta-Lactamase VIM-2 in complex with 1-benzyl-1H-imidazole-2-carboxylic acidmonomer32-262
ZN;FZX;FMT;
Assess
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-heptylthiazole-4-carboxylic acidmonomer32-262
ZN;5ZR;FMT;
Assess
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-(4-methoxybenzyl)thiazole-4-carboxylic …monomer32-262
ZN;4YJ;
Assess
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-hexylthiazole-4-carboxylic acidmonomer32-262
ZN;5ZD;
Assess
Crystal structure of VIM-2 MBL in complex with 1-benzyl-5-methyl-1H-imidazole-2-carboxylic acidmonomer32-262
ZN;HQ3;
Assess
Crystal structure of VIM-2 MBL in complex with 1-(but-3-en-1-yl)-5-methyl-1H-imidazole-2-carboxylic…monomer32-262
ZN;HQ0;
Assess
VIM-2_1cc-. Triazole inhibitors with promising inhibitor effects against antibiotic resistance meta…monomer32-261
9NW;ZN;OH;
Assess
Structure of VIM-2 bound to QPX7728 at 1.20 Amonomer33-262
QNA;ZN;ACT;GOL;
Assess
VIM-2 metallo-beta-lactamase in complex with ((S)-3-mercapto-2-methylpropanoyl)-D-tryptophan (Compo…monomer33-262
ZN;R38;FMT;
Assess
Structure of the VIM-2 Metallo-beta-Lactamase in Complex with a Bisthiazolidine Inhibitormonomer30-259
ZN;GOL;3C7;
Assess
VIM-2_1dh-Triazole inhibitors with promising inhibitor effects against antibiotic resistance metall…monomer32-261
NL5;ZN;OH;IOD;
Assess
Crystal structure of VIM-2 complexed with compound 8monomer32-261
ZN;P9T;ACT;
Assess
VIM-2_1di-Triazole inhibitors with promising inhibitor effects against antibiotic resistance metall…monomer32-261
ZN;OH;CL;
Assess
Structure of Zn(II)-bound metallo-beta-lactamse VIM-2 from Pseudomonas aeruginosamonomer32-261
ZN;ACT;
Assess
VIM-2_10c. Metallo-beta-Lactamase Inhibitors by Bioisosteric Replacement: Preparation, Activity and…monomer32-261
ZN;8XW;
Assess
Crystal Structure of the VIM-2 Acquired Metallo-beta-Lactamase in Complex with Taniborbactam (VNRX-…monomer32-261
ZN;ACT;K9B;
Assess
VIM-2_10b. Metallo-beta-Lactamase Inhibitors by Bioisosteric Replacement: Preparation, Activity and…monomer32-261
ZN;8XZ;CL;PO4;
Assess
VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa with Cys221 reducedmonomer32-261
ZN;ACT;CL;OH;
Assess
VIM-2 metallo-beta-lactamase in complex with (S)-1-allyl-2-(3-methoxyphenyl)-3-oxoisoindoline-4-car…monomer33-262
ZN;6TU;
Assess
VIM-2 metallo-beta-lactamase in complex with (R)-2-(4-fluorophenyl)-2-((S)-3-mercapto-2-methylpropa…monomer32-261
ZN;8PL;FMT;
Assess
VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa with an oxidized Cys (cysteinesulfonic)monomer32-261
ZN;ACT;
Assess
Crystallographic Investigation of Inhibition Mode of the VIM-2 Metallo-beta-lactamase from Pseudomo…monomer32-256
ZN;SO4;M5P;
Assess
VIM-2 metallo-beta-lactamase in complex with 3-oxo-2-phenylisoindoline-4-carboxylic acid (compound …monomer39-260
ZN;MG;6TJ;GOL;
Assess
VIM-2 metallo-beta-lactamase in complex with 3-oxo-2-(3-(trifluoromethyl)phenyl)isoindoline-4-carbo…monomer39-260
ZN;B06;GOL;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6kw1.1.Ahomo-2-mer0.9332-262
ZN;MG;9RX;100.00
Assess
6bm9.2.Ahomo-2-mer0.8532-261
ZN;93.75
Assess